European CHMP recommends license extension of belatacept (Nulojix) in renal transplantation
The proposed license extension, in combination with corticosteroids and a mycophenolic acid, is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
Source:
European Medicines Agency